Table 1 Results of the conservative management and the expression of Ki-67 antigen

From: Prognostic and proliferative evaluation of ameloblastoma based on radiographic boundary

  

Results of therapy

LI of Ki-67 antigen

 

Group

N

Tumor-free

Recurrence

Range/%

Mean±s.d./%

Recurrent rate/%

Group Ia

24

17

7

0.94–4.06

2.06±0.82

29.2

Group IIa

41

23

18

1.93–7.42

3.17±1.23

43.9

Group IIIa

32

12

20

1.06–8.43

4.25±1.01

62.5

  1. Abbreviation: LI, label index.
  2. a Group I: well-defined with sclerosis; group II: well-defined without sclerosis; group III: ill-defined.
Back to article page